TN
Therapeutic Areas
Arbutus Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Imdusiran (AB-729) | Chronic Hepatitis B Virus (HBV) | Phase 2 |
| AB-101 | Chronic Hepatitis B Virus (HBV) | Phase 1/2 |
| AB-161 | Chronic Hepatitis B Virus (HBV) | Phase 1 |
Leadership Team at Arbutus Biopharma
LA
Lindsay Androski
President & CEO and Chairperson
AJ
Andrew J. Sung
General Counsel
RB
Robert Beardsley
Director
JB
Joseph Bishop
Director
JJ
Jordan J. Feld
Scientific Advisory Board Member
EG
Ed Gane
Scientific Advisory Board Member
HL
Harry L.A. Janssen
Scientific Advisory Board Member